Seeded root objective
Seeded quick objective

[sim] "Find a cure for cancer"
[sim] 1 message(s) | /tmp/aria-sim-1774708310167.db

[spawn] 298a7a3f model=opus (resolved)
[298a7a3f] Session: 5f4f1073-bf1b-42cc-a0bd-da6659be0758
[298a7a3f] aria tree 2>&1 | head -80
[298a7a3f] aria show 298a7a3f-ec54-4bbd-b6b8-4306fb9e9743 2>&1
[298a7a3f] aria inbox 298a7a3f-ec54-4bbd-b6b8-4306fb9e9743 2>&1 | head -50
[298a7a3f] aria create "Current cancer research frontier is mapped — most promising approaches, biggest bottlenecks, and where breakthroughs are closest (2024-2026)" "## Task
Research the current state of cancer treatment and research as of 2025-2026. Map the frontier.

## Focus Areas
1. **Most promising therapeutic approaches** — immunotherapy (CAR-T, checkpoint inhibitors, cancer vaccines), targeted therapy, microRNA therapeutics, gene editing (CRISPR), radiopharmaceuticals, ADCs (antibody-drug conjugates)
2. **Where are we closest to breakthroughs?** — Which cancer types are becoming curable? What's in late-stage clinical trials that looks transformative?
3. **Biggest bottlenecks** — What's blocking progress? (tumor heterogeneity, drug resistance, delivery mechanisms, regulatory, cost)
4. **Underexplored angles** — What approaches are promising but underfunded or overlooked?

## Output
Return a structured summary directly. Cover each focus area with specifics — names, institutions, trial phases, mechanisms. Not a textbook overview — the bleeding edge.

## Success Criteria
Someone reading this should understand: what's working, what's close, what's stuck, and where an outsider could have the most impact.

## Restrictions
Research only. Use web search extensively. Focus on 2024-2026 developments." 2>&1
[298a7a3f] aria create "Computational and AI approaches to cancer research are mapped — what can be done with code and compute" "## Task
Research how computation and AI are being used to advance cancer research RIGHT NOW, and what approaches are most accessible to a small team or individual with strong technical skills.

## Focus Areas
1. **AI drug discovery** — AlphaFold, diffusion models for molecule generation, virtual screening. What's actually working vs hype?
2. **Genomics/bioinformatics** — Analyzing cancer genomes, finding new targets, biomarker discovery. What public datasets exist (TCGA, GEO, etc.)?
3. **Machine learning for treatment** — Predicting drug response, optimizing combinations, personalized medicine
4. **Protein engineering** — Designing better antibodies, CAR constructs, delivery vehicles computationally
5. **Open problems** — What specific computational problems, if solved, would accelerate cancer cures?

## Output
Return structured summary directly. For each area: what's the state of the art, what tools/data are publicly available, and what could a skilled individual actually contribute.

## Success Criteria
Actionable map of where computation meets cancer research, with specific tools, datasets, and open problems.

## Restrictions
Research only. Web search extensively. Focus on practical, accessible approaches — not things that require a $100M lab." 2>&1
[298a7a3f] aria create "MicroRNA-based cancer therapeutics landscape is understood — current state, key players, and opportunities" "## Task
Deep dive on microRNA (miRNA) as a cancer therapeutic approach. This is a specific area of interest.

## Context
Frank Slack co-discovered let-7 microRNA and is developing microRNA-based cancer therapeutics. miR-34 has been in Phase I clinical trials. This is a known area of interest.

## Focus Areas
1. **Current state of miRNA therapeutics** — What trials are active? What happened with miR-34 (Mirna Therapeutics/Synlogic)? Any new candidates?
2. **Delivery problem** — The biggest challenge. What delivery mechanisms are being tried? (LNPs, exosomes, viral vectors, conjugates)
3. **Key labs and companies** — Who's leading? Frank Slack, others?
4. **Computational angles** — Can AI/computation help with miRNA target prediction, delivery optimization, or identifying new therapeutic miRNAs?
5. **What killed previous attempts?** — Why did early trials fail? What's different now?

## Output
Return structured summary directly.

## Success Criteria
Clear picture of whether miRNA therapeutics is a viable path, what the blockers are, and where computational work could help.

## Restrictions
Research only. Web search." 2>&1
[298a7a3f] aria wait "Three research children running in parallel: (1) cancer research frontier mapping, (2) computational approaches to cancer, (3) miRNA therapeutics deep dive. Waiting for results to synthesize into an actionable strategy." 2>&1

── children created (3) ──────────────────────────────────
  [idle] "MicroRNA-based cancer therapeutics landscape is understood — current state, key players, and opportunities"
  [idle] "Computational and AI approaches to cancer research are mapped — what can be done with code and compute"
  [idle] "Current cancer research frontier is mapped — most promising approaches, biggest bottlenecks, and where breakthroughs are closest (2024-2026)"

── final status: idle
   waiting on: Three research children running in parallel: (1) cancer research frontier mapping, (2) computational approaches to cancer, (3) miRNA therapeutics deep dive. Waiting for results to synthesize into an actionable strategy.

file:///Users/maxwraae/Library/Mobile%20Documents/com%7Eapple%7ECloudDocs/Aria/engine/dist/db/queries.js:40
    return stmt(db, "getObjective", "SELECT * FROM objectives WHERE id = ?").get(id);
                                                                             ^

TypeError: The database connection is not open
    at getObjective (file:///Users/maxwraae/Library/Mobile%20Documents/com%7Eapple%7ECloudDocs/Aria/engine/dist/db/queries.js:40:78)
    at ChildProcess.<anonymous> (file:///Users/maxwraae/Library/Mobile%20Documents/com%7Eapple%7ECloudDocs/Aria/engine/dist/engine/output.js:125:21)
    at ChildProcess.emit (node:events:519:28)
    at maybeClose (node:internal/child_process:1101:16)
    at Socket.<anonymous> (node:internal/child_process:456:11)
    at Socket.emit (node:events:519:28)
    at Pipe.<anonymous> (node:net:346:12)

Node.js v22.22.0
